πΌ Deal
MedTech
Placeholder
Pacific Diabetes Technology
Investment deal profile β Pacific Diabetes Technology (PDT)
Stage
β
Ask
β
Valuation
β
Status
Pending
Deal Sections
Company Overview
βΊ
Founded, HQ location, founding team, mission, product/service description, stage of development, and regulatory status.
Founded
HQ
Team size
Product description
FDA status
IP / patents
Investment Thesis
βΊ
Why this deal is compelling. Market size, competitive moat, timing, and Robert's strategic fit with this investment.
Market size (TAM/SAM)
Competitive moat
Timing thesis
Exit scenarios
Risk factors
Deal Terms
βΊ
Offering type, valuation, minimum check size, lead investor, co-investors, use of proceeds, and pro-rata rights.
| Offering Type | β |
| Pre-money Valuation | β |
| Round Size | β |
| Min. Check | β |
| Lead Investor | β |
| Closing Date | β |
Key Contacts
βΊ
Founders, key team members, board members, and deal introduction source.
CEO
CTO
Board
Intro source
Timeline
βΊ
Key dates: first contact, due diligence milestones, term sheet, close, and post-investment check-ins.
First contact
DD start
Term sheet
Close target
Updates
βΊ
Running log of deal updates, investor updates, and notable events post-investment.
No updates yet.